Macsek, P.; Skoda, J.; Krchniakova, M.; Neradil, J.; Veselska, R.
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma. Int. J. Mol. Sci. 2022, 23, 376.
https://doi.org/10.3390/ijms23010376
AMA Style
Macsek P, Skoda J, Krchniakova M, Neradil J, Veselska R.
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma. International Journal of Molecular Sciences. 2022; 23(1):376.
https://doi.org/10.3390/ijms23010376
Chicago/Turabian Style
Macsek, Peter, Jan Skoda, Maria Krchniakova, Jakub Neradil, and Renata Veselska.
2022. "Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma" International Journal of Molecular Sciences 23, no. 1: 376.
https://doi.org/10.3390/ijms23010376
APA Style
Macsek, P., Skoda, J., Krchniakova, M., Neradil, J., & Veselska, R.
(2022). Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma. International Journal of Molecular Sciences, 23(1), 376.
https://doi.org/10.3390/ijms23010376